Grade My Investments

Baxter International Inc. (BAX) Stock Grade

BAX · Healthcare

C+
Grade updated: August 16, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$13.8B
P/E Ratio
Revenue Growth (YoY)
+5.7%
Net Margin
-8.5%
Return on Equity
Dividend Yield
1.9%

About Baxter International Inc.'s fundamentals

Baxter International is a $9.8 billion healthcare company in the medical instruments and supplies sector that grew revenue 5.7% year-over-year, though it reported a net loss resulting in a negative 8.5% net margin in its latest annual statement. Despite the accounting losses, the company generated positive free cash flow and maintains a 2.7% dividend yield. The company's current financial position reflects operational cash generation even as profitability remains pressured.

Track BAX free — no credit card required. Live grade + monthly AI report →